125 related articles for article (PubMed ID: 15781316)
1. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Rio MC
Biochimie; 2005; 87(3-4):299-306. PubMed ID: 15781316
[TBL] [Abstract][Full Text] [Related]
2. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
[TBL] [Abstract][Full Text] [Related]
3. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa KL; Boulay A; Masson R; Mathelin C; Stoll I; Tomasetto C; Chenard MP; Gintz M; Bellocq JP; Rio MC
Cancer Res; 2003 Sep; 63(18):5844-9. PubMed ID: 14522908
[TBL] [Abstract][Full Text] [Related]
4. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
Boulay A; Masson R; Chenard MP; El Fahime M; Cassard L; Bellocq JP; Sautès-Fridman C; Basset P; Rio MC
Cancer Res; 2001 Mar; 61(5):2189-93. PubMed ID: 11280785
[TBL] [Abstract][Full Text] [Related]
5. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
6. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM
Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
8. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Wolf C; Rouyer N; Lutz Y; Adida C; Loriot M; Bellocq JP; Chambon P; Basset P
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1843-7. PubMed ID: 8446598
[TBL] [Abstract][Full Text] [Related]
9. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
Amano T; Kwak O; Fu L; Marshak A; Shi YB
Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Masson R; Lefebvre O; Noël A; Fahime ME; Chenard MP; Wendling C; Kebers F; LeMeur M; Dierich A; Foidart JM; Basset P; Rio MC
J Cell Biol; 1998 Mar; 140(6):1535-41. PubMed ID: 9508784
[TBL] [Abstract][Full Text] [Related]
12. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Basset P; Wolf C; Chambon P
Breast Cancer Res Treat; 1993; 24(3):185-93. PubMed ID: 8435474
[TBL] [Abstract][Full Text] [Related]
13. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis.
Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH
Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.
Liaudet-Coopman E; Beaujouin M; Derocq D; Garcia M; Glondu-Lassis M; Laurent-Matha V; Prébois C; Rochefort H; Vignon F
Cancer Lett; 2006 Jun; 237(2):167-79. PubMed ID: 16046058
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Santavicca M; Noel A; Chenard MP; Lutz Y; Stoll I; Segain JP; Rouyer N; Rio MC; Wolf C; Belloco JP
Int J Cancer; 1995 Oct; 64(5):336-41. PubMed ID: 7591307
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Ahmad A; Marshall JF; Basset P; Anglard P; Hart IR
Int J Cancer; 1997 Oct; 73(2):290-6. PubMed ID: 9335457
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 in the biology of the normal and neoplastic mammary gland.
Rio MC; Lefebvre O; Santavicca M; Noël A; Chenard MP; Anglard P; Byrne JA; Okada A; Régnier CH; Masson R; Bellocq JP; Basset P
J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):231-40. PubMed ID: 10887496
[TBL] [Abstract][Full Text] [Related]
18. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
Lefebvre O; Wolf C; Limacher JM; Hutin P; Wendling C; LeMeur M; Basset P; Rio MC
J Cell Biol; 1992 Nov; 119(4):997-1002. PubMed ID: 1429845
[TBL] [Abstract][Full Text] [Related]
19. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
20. Spatio-temporal regulation and cleavage by matrix metalloproteinase stromelysin-3 implicate a role for laminin receptor in intestinal remodeling during Xenopus laevis metamorphosis.
Amano T; Fu L; Marshak A; Kwak O; Shi YB
Dev Dyn; 2005 Sep; 234(1):190-200. PubMed ID: 16059908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
